statements Revenues 1. Total sales and Total Revenues from hire of work of 791.62 Million Baht was 34.59 Million Baht or 4.57% increase from the last year. This was the result of the orders of more customers
sales expenses (excluding ownership transfer expenses) increase 46.18% as a result of the brokerage fee from the recognized income of 25.62 million THB of Lumpini Suite Petchaburi - Makkasan. Main income
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
of the Newly Issued Ordinary Shares of the Company through a Private Placement which is a Connected Transaction, Capital Reduction, Capital Increase, Entering into the Right to Sell Advertising Media
of the Newly Issued Ordinary Shares of the Company through a Private Placement which is a Connected Transaction, Capital Reduction, Capital Increase, Entering into the Right to Sell Advertising Media
from sale for Q2/2018 ended June 30, 2018 of Baht 93.21 million, compare with the same period of previous year amount to Baht 85.15 million which increase Baht 8.06 million or 9.46%, which main result
years ending 31 December 2016 and 2017, total revenue increased from THB 2,181.9 Mn to THB 2,515.2 Mn respectively. This was an increase of THB 333.3 Mn or 15.3% and was mainly due to the increased
baht, respectively. It increase 151.26 million baht or 31.10% when compared with Q3/2020. The reason for the increase income as a result increased sales of foreign products, the company has expanded the
million baht, respectively. It increase 3 2 .8 0 million baht or 5 .1 4 % when compared with Q3/2021. The reason for the increase income as a result increased sales of foreign products. and the company
expense must be paid due to the tender offer process in May 2019 of 26.14% from the acquisition of GLOW. This results in the company to hold 95.25% share in GLOW. The company have also faced an increase in